These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18679176)

  • 1. Pharmacoeconomics in the era of individualized medicine.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2008 Aug; 84(2):179-82. PubMed ID: 18679176
    [No Abstract]   [Full Text] [Related]  

  • 2. When will the U.S. flinch at cancer drug prices?
    Vanchieri C
    J Natl Cancer Inst; 2005 May; 97(9):624-6. PubMed ID: 15870428
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacoeconomics and cost of cancer drugs].
    Camps Herrero C; Caballero Díaz C; Blasco Cordellat A
    Farm Hosp; 2010 Mar; 34 Suppl 1():12-5. PubMed ID: 20920852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No rational theory for drug pricing.
    Cox MC; Figg WD; Thurman PW
    J Clin Oncol; 2004 Mar; 22(5):962-3. PubMed ID: 14990657
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacoeconomics. Potent drugs, diseases are costly].
    Flaten O
    Tidsskr Nor Laegeforen; 1994 Apr; 114(11):1345-6. PubMed ID: 8079219
    [No Abstract]   [Full Text] [Related]  

  • 7. The power of pharmacoeconomics.
    Healthc Exec; 2000; 15(1):44-5. PubMed ID: 11067028
    [No Abstract]   [Full Text] [Related]  

  • 8. Considerations in the pharmacoeconomics of glaucoma.
    Hirsch JD
    Manag Care; 2002 Nov; 11(11 Suppl):32-7. PubMed ID: 15357537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using pharmacoeconomics to value pharmacotherapy.
    Hay JW
    Clin Pharmacol Ther; 2008 Aug; 84(2):197-200. PubMed ID: 18679182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomics: determining the value of drug therapy.
    Peterson C
    Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751
    [No Abstract]   [Full Text] [Related]  

  • 11. [Economic effects of "molecular" medicine].
    Riemann JF
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
    [No Abstract]   [Full Text] [Related]  

  • 12. Observational studies and "real world" anesthesia pharmacoeconomics.
    Miller DR; Tierney M
    Can J Anaesth; 2002 Apr; 49(4):329-34. PubMed ID: 11927469
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution?
    Alifrangis C; Krell J; Stebbing J
    Eur J Cancer; 2011 Jun; 47(9):1285-6. PubMed ID: 21550231
    [No Abstract]   [Full Text] [Related]  

  • 14. Keynote comment: reimbursement for molecularly targeted anticancer agents.
    Tirelli U; de Castro G; Awada A
    Lancet Oncol; 2006 Jan; 7(1):2-3. PubMed ID: 16389172
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacoeconomics. A new concept of an old practice].
    Palma-Aguirre JA
    Gac Med Mex; 1998; 134(5):621-4. PubMed ID: 9842147
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacoeconomics: historical perspective.
    Bootman JL; McGhan WF; Townsend RJ
    Ann Pharmacother; 2006 Mar; 40(3):518-9. PubMed ID: 16478813
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost of Cancer Drugs: Something Has To Give.
    Bender E
    Manag Care; 2018 May; 27(5):18-22. PubMed ID: 29763403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value.
    Serritella AV; Strohbehn GW; Goldstein DA; Lichter AS; Ratain MJ
    Clin Pharmacol Ther; 2020 Sep; 108(3):487-493. PubMed ID: 32298471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness.
    Messori A; Trippoli S; Vaiani M
    BMJ; 2002 Nov; 325(7375):1302; author reply 1302. PubMed ID: 12463189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.